SCHEMBL13997654

SCHEMBL13997654

O=C(CCC(=O)c1ccccc1)ON1C(=O)CCC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.49
KMT2A Q03164 5/20 0.46
MAPT P10636 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
ALDH1A1 P00352 7/20 0.45
GAA P10253 1/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MGLL Q99685 1/20 0.44
CTNNB1 P35222 4/20 0.43
WNT3A P56704 3/20 0.43
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21392317 0.91 SMN1; SMN2 (0.57) KMT2AMAPTL3MBTL1MEN1HPGD
SCHEMBL10720603 0.91 L3MBTL1 (0.50) NR4A2KMT2AMAPTL3MBTL1ALDH1A1
SCHEMBL11064187 0.85 NPC1 (0.49) KMT2AMAPTL3MBTL1MEN1HPGD
SCHEMBL27463054 0.85 MGLL (0.42) KMT2AHPGDALDH1A1RAB9ASMN1; SMN2
SCHEMBL17521947 0.84 ALDH1A1 (0.39) NR4A2KMT2AALDH1A1GAACYP2C19
SCHEMBL28775923 0.81 ALDH1A1 (0.60) NR4A2KMT2AMAPTL3MBTL1MEN1
SCHEMBL43576 0.81 PSMB8 (0.35) KMT2AHPGDLMNASMN1; SMN2MGLL
SCHEMBL9211737 0.80 KMT2A (0.42) KMT2AHPGDALDH1A1RAB9ASMN1; SMN2
SCHEMBL436079 0.79 TDP1 (0.54) KMT2AMAPTL3MBTL1MEN1HPGD
SCHEMBL31522720 0.79 PSMB8 (0.34) KMT2AHPGDLMNASMN1; SMN2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080305986-A1 Multimers of Peptides CONDE FIEBOES KILLIAN WALDEMAR 2008-12-11 US disclosed
US-20080305986-A1 Multimers of Peptides CONDE FIEBOES KILLIAN WALDEMAR 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305986-A1 Multimers of Peptides IAPP, NGLY1, VIP NR4A2 3250/4885KMT2A 4782/4885MAPT 1011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.